Clinical data | Fracture Number (%) | p | ||
Yes | Non | |||
Age | <65 ans | 15 (86.7%) | 70 (88.6%) | 0.265 |
>65 ans | 4 (13.3%) | 9 (11.4%) |
| |
Gender | F | 14 (53.1%) | 38 (48.1%) | 0.045 |
M | 5 (46.9%) | 41 (51.9%) | ||
Seniority in dialysis | >60 month | 16 (80.6%) | 16 (20.3%) | 0.049 |
BMI < 18.5 kg/m2 |
| 6 (36.7%) | 30 (38%) | 0.604 |
Gait disorder |
| 13 (13.26%) | 85 (86.73%) | 0.001 |
Hb < 12 g/dl | 17 (17.34%) | 81 (82.66%) | 0.604 | |
Serum calcium < 85 mg/L | 3 (3.06%) | 95 (96.94%) | 0.675 | |
Serum phosphorus < 35 mg/L | 11 (11.22%) | 86 (87.78%) | 0.346 | |
25(OH) Vit D < 30 ng/ml | 13 (13.20%) | 80 (86.80%) | 0.578 | |
PTHi | <130 pg/ml | 3 (3.06%) | 5 (5.10%) | 0.427 |
>585 pg/ml | 13 (13.26%) | 59 (60.20%) | 0.427 | |
Albuminemia < 40 g/L | 9 (19.60%) | 37 (80.40%) | 0.389 | |
CRP > 6 mg/L | 8 (10.09%) | 65 (89.04%) | 0.028 | |
Vascular calcification | 5 (5.10%) | 93 (94.89%) | 0.002 | |
Native Vitamin D | 12 (60%) | 48 (80%) | 0.847 | |
Alfacalcidol | 9 (42.9%) | 12 (57.1%) | 0.002 | |
Calcimimetic | 0 (0%) | 7 (100%) | 0.178 |